Mold-Tek Packaging Limited — Updates, 07-02-2025: Press Release

Q3 FY 2025 results from Mold-Tek Packaging Limited show a solid performance with a **15.25%** increase in sales compared to Q3 FY 2024, amounting to **₹190.69 crore**. Sales volume also saw a **7.50%** rise, totaling **9,255 MT**. The EBITDA rose to **₹33.98 crore**, an increase of **11.94%**, while net profit after tax dipped **3.90%** to **₹13.64 crore**, influenced by higher finance costs and depreciation due to significant past investments of over **₹250 crore**.

For the nine-month period, revenue increased by **10.91%** to **₹578.71 crore**, and EBITDA grew by **6.17%** to **₹104.78 crore**, but PAT saw a decline of **8.91%** to **₹44.28 crore**. Mold-Tek's expansion into pharmaceuticals is gaining traction, highlighted by a **0.63%** volume growth in pharma packs, and they are planning to double capacity soon. The outlook remains positive, driven by rising demand and new partnerships. Investors should continue to monitor developments closely, particularly in the expanding pharma segment.